Nilo Therapeutics

Developer of therapies targeting neural circuits for immune and inflammatory diseases

placeNew York City, New York, United States calendar_todayFounded 2024 language nilotx.com

Social engagement

Social engagement: 4K social following, 2 posts in the last 12 months — top quartile of its industry.

Investor mix

5 investors on record; lead investors include The Column Group, DCVC, Lux Capital.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

4 May 2026 · Senior Scientist, Immunology

Based on job postings tracked across public sources.

Coming soon